The Board has determined that the Veteran's bone marrow disorder is not related to his service, including presumed herbicide exposure in Vietnam. The condition was diagnosed many years after service and there is no direct evidence linking it to service.
The deciding factor: The medical opinions provided by VA oncologists found insufficient evidence to establish a connection between the Veteran's bone marrow disorder and his presumed herbicide exposure during service.
- Claimed conditions
- myeloproliferative neoplasm, essential thrombocytosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- August 20, 2014
- Citation
- 1437325
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1437325.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has determined that the evidence is in equipoise regarding whether the Veteran's essential thrombocytosis is related to service, specifically herbicide exposure. As such, the claim for service connection is granted.
- Whole decision: Granted
The Board has granted an earlier effective date of December 7, 2018 for the award of service connection for myeloproliferative neoplasm due to exposure to Agent Orange during active service.
- Whole decision: Remanded (sent back)
The Board remands the claim for essential thrombocytosis to obtain an addendum opinion addressing all toxic exposure risks, including herbicides.
- Whole decision: Denied
The Board denied the Veteran's claim for an initial compensable rating for essential thrombocytosis as there was no evidence of continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.